-
1 Comment
Sichuan Goldstone Asia Pharmaceutical Inc is currently in a long term uptrend where the price is trading 2.9% above its 200 day moving average.
From a valuation standpoint, the stock is 26.9% cheaper than other stocks from the Industrials sector with a price to sales ratio of 3.7.
Sichuan Goldstone Asia Pharmaceutical Inc's total revenue sank by 22.6% to $147M since the same quarter in the previous year.
Its net income has dropped by 705.9% to $-99M since the same quarter in the previous year.
Finally, its free cash flow fell by 24.8% to $20M since the same quarter in the previous year.
Based on the above factors, Sichuan Goldstone Asia Pharmaceutical Inc gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001YX5 |
| Sector | Industrials |
| Industry | Industrial Distribution |
| Dividend Yield | 1.4% |
|---|---|
| Market Cap | 3B |
| PE Ratio | 77.6 |
| Target Price | None |
| Beta | 0.3 |
Sichuan Goldstone Asia Pharmaceutical Inc. engages in the research, development, and sale of medicines and health products in China. It produces and sells plastic composite pipes, pipe fittings and equipment, as well as develops vacuum coating, industrial machinery, pipe fitting molds, construction equipment, and special equipment. The company produces, installs, and maintains special equipment. It also imports and exports spare parts, raw, and auxiliary materials. Sichuan Goldstone Asia Pharmaceutical Inc. was founded in 2001 and is based in Chengdu, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300434.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
